violacein has been researched along with Colorectal Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Akagi, EM; Carvalho, HF; Clerici, SP; de Souza Oliveira, PF; Durán, N; Faria, AVS; Ferreira-Halder, CV; Justo, GZ | 1 |
| Clerici, SP; de Lima, TI; Durán, N; Faria, AVS; Fernandes-Oliveira, PS; Ferreira-Halder, CV; Fonseca, EMB; Justo, GZ; Silveira, LR | 1 |
| Bos, CL; Durán, N; Ferreira, CV; Hardwick, JC; Kodach, LL; Peppelenbosch, MP | 1 |
3 other study(ies) available for violacein and Colorectal Cancer
| Article | Year |
|---|---|
Violacein negatively modulates the colorectal cancer survival and epithelial-mesenchymal transition.
Topics: Cell Line, Tumor; Cell Movement; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; ErbB Receptors; Humans; Indoles | 2022 |
Violacein switches off low molecular weight tyrosine phosphatase and rewires mitochondria in colorectal cancer cells.
Topics: Colorectal Neoplasms; Humans; Indoles; Male; Mitochondria; Molecular Weight; Protein Tyrosine Phosphatases; Tyrosine | 2022 |
Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Colorectal Neoplasms; Down-Regulation; Drug Interactions; Fluorouracil; Humans; Indoles; NF-kappa B; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Tumor Cells, Cultured | 2006 |